Your Patients Need Your Help Finding Epsolay

You've prescribed Epsolay (Benzoyl Peroxide cream, 5%) because it's the right treatment for your patient's papulopustular rosacea. But increasingly, patients are returning to your office frustrated — their pharmacy doesn't carry it, their insurance is creating barriers, or the cost is prohibitive.

As the prescriber, you're uniquely positioned to help. This guide provides a practical, step-by-step framework for improving Epsolay access within your practice workflow. The strategies here are designed to be implementable by your clinical staff without adding significant burden to an already busy practice.

Current Availability: What's Happening in 2026

Epsolay is not in a formal FDA shortage. The availability challenges are driven by market dynamics:

• Retail stocking: Many chain pharmacies don't stock Epsolay due to its high unit cost ($545-$1,034 per 30g tube) and relatively low prescription volume
• Insurance gatekeeping: Prior authorization and step therapy requirements reduce fill rates
• No generic: The microencapsulated Benzoyl Peroxide formulation has no generic equivalent, keeping costs elevated
• Ordering is possible: Any pharmacy can order Epsolay through standard wholesaler channels, typically within 1-3 business days

For a complete availability analysis, see our provider shortage briefing.

Why Patients Can't Find Epsolay

Understanding the patient experience helps you anticipate and address barriers:

The Pharmacy Experience

A typical patient scenario looks like this:

1. Patient leaves your office with an Epsolay prescription
2. Goes to their usual pharmacy (often a chain)
3. Pharmacy doesn't have it in stock — may not even recognize the product name
4. Patient is told it needs to be ordered (wait 2-3 days) or isn't available
5. Insurance may reject the claim, requiring prior authorization
6. Patient becomes frustrated and may abandon the prescription entirely

The Insurance Experience

Many payers require:

• Prior authorization: Clinical justification before coverage is approved
• Step therapy: Documentation of failure on generic Metronidazole and/or Azelaic Acid
• High-tier copay: Even with approval, copays can be $50-$100+ on specialty tiers

These barriers mean a significant portion of Epsolay prescriptions never get filled. For patients who need this medication, that's a clinical problem — not just an administrative one.

What Providers Can Do: 5 Actionable Steps

Step 1: Set Expectations at the Point of Prescribing

The most impactful thing you can do is prepare the patient before they leave your office:

• Explain that Epsolay is a specialty medication that may not be immediately available at every pharmacy
• Provide the Mayne Pharma Patient Savings Card information (as low as $0 with commercial insurance, $75 without)
• Direct them to Medfinder to check pharmacy stock before going
• Identify a preferred pharmacy that reliably carries Epsolay or can order it quickly

A 60-second conversation at the end of the visit can prevent days of patient frustration.

Step 2: Establish Preferred Pharmacy Relationships

Identify 1-2 pharmacies in your area that either stock Epsolay or have a proven track record of quick ordering:

• Independent pharmacies: Often more flexible with ordering specialty products
• Dermatology-focused pharmacies: If any exist in your area, they're ideal
• Specialty pharmacies: May have broader specialty drug inventories

Route Epsolay prescriptions to these preferred pharmacies by default. Communicate this preference to your front desk and clinical staff so it becomes part of the standard workflow.

Step 3: Streamline Prior Authorization

Create a template or standard language for Epsolay prior authorization requests:

• Emphasize that Epsolay is the only FDA-approved microencapsulated Benzoyl Peroxide for rosacea — there is no generic equivalent
• Document any prior treatment failures (Metronidazole, Azelaic Acid, Ivermectin)
• Note that standard OTC Benzoyl Peroxide is not an appropriate substitute due to irritation risk on rosacea skin
• Include relevant clinical trial data showing efficacy in papulopustular rosacea

Having this template ready reduces staff time per authorization from 20-30 minutes to 5-10 minutes.

Step 4: Provide Bridge Supplies When Possible

If your practice has Epsolay samples:

• Offer a bridge supply to patients while they navigate insurance or pharmacy sourcing
• This maintains treatment continuity and demonstrates the medication's efficacy, which can support insurance appeals
• Even 1-2 sample tubes can cover the 1-3 business days needed for a pharmacy order

Step 5: Equip Your Staff With Resources

Ensure your clinical team has quick access to:

• Medfinder: Real-time pharmacy stock checker
• Savings card link: epsolay.com/savings-and-support for the Mayne Pharma Patient Savings Card
• A one-page patient handout explaining how to find Epsolay, including the savings card information and tips for working with their pharmacy

Alternative Treatments to Consider

When Epsolay access is delayed or impossible, consider these evidence-based alternatives:

• Metronidazole 0.75%-1% (generic): Widely available, affordable ($15-$50 with coupon). First-line for most payers.
• Azelaic Acid 15% gel/foam: Generic available ($30-$80 with coupon). Anti-inflammatory with mild antimicrobial activity.
• Ivermectin 1% cream (Soolantra): Once daily, targets Demodex mites. Brand-name cost is high but savings programs exist.
• Minocycline 1.5% foam (Zilxi): Once daily topical antibiotic. No generic available.
• Oral Doxycycline 40mg MR (Oracea or generic): Sub-antimicrobial dose for anti-inflammatory effect. Can be combined with topical therapy.

For a patient-friendly comparison, share our alternatives guide.

Workflow Integration Tips

To make these steps sustainable in a busy practice:

For Front Desk/Scheduling Staff

• When patients call about Epsolay access issues, direct them to Medfinder and the savings card website
• Have the preferred pharmacy contact information readily available
• Flag returning rosacea patients in the schedule for potential prescription access follow-up

For Clinical Staff (MAs, NPs, PAs)

• Add savings card distribution to the post-visit workflow for Epsolay prescriptions
• Keep a prior authorization template updated and accessible in your EHR
• Track prior authorization outcomes to identify which payers are most challenging

For Prescribers

• Set the preferred pharmacy as default in your e-prescribing system for Epsolay
• Consider documenting step therapy failures proactively in the patient chart, even before switching to Epsolay
• Use the provider savings guide as a reference for cost discussions with patients

Final Thoughts

Epsolay is a clinically differentiated treatment that fills an important gap in rosacea management. While access barriers exist, they are navigable with the right systems in place. By establishing preferred pharmacy relationships, streamlining prior authorizations, leveraging savings programs, and using tools like Medfinder, your practice can significantly improve Epsolay fill rates and patient satisfaction.

The investment in workflow optimization pays dividends across all specialty dermatology prescriptions — not just Epsolay. A practice that's good at getting patients on Epsolay will also be good at navigating access for other specialty products.

For the patient perspective on availability challenges, see our guide on what patients need to know about the Epsolay shortage in 2026.